323 related articles for article (PubMed ID: 24526353)
1. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
[TBL] [Abstract][Full Text] [Related]
2. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
[TBL] [Abstract][Full Text] [Related]
3. Muscle ring finger 1 mediates cardiac atrophy in vivo.
Willis MS; Rojas M; Li L; Selzman CH; Tang RH; Stansfield WE; Rodriguez JE; Glass DJ; Patterson C
Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H997-H1006. PubMed ID: 19168726
[TBL] [Abstract][Full Text] [Related]
4. Rise above: muscle ring-finger-1 (MURF1) regulation of cardiomyocyte size and energy metabolism.
Patterson C; Willis MS; Portbury A
Trans Am Clin Climatol Assoc; 2011; 122():70-81. PubMed ID: 21686210
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.
Parry TL; Desai G; Schisler JC; Li L; Quintana MT; Stanley N; Lockyer P; Patterson C; Willis MS
Cardiovasc Pathol; 2016; 25(2):127-140. PubMed ID: 26764147
[TBL] [Abstract][Full Text] [Related]
6. MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo.
Wadosky KM; Berthiaume JM; Tang W; Zungu M; Portman MA; Gerdes AM; Willis MS
J Mol Endocrinol; 2016 Apr; 56(3):273-90. PubMed ID: 26862156
[TBL] [Abstract][Full Text] [Related]
7. MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.
Baskin KK; Rodriguez MR; Kansara S; Chen W; Carranza S; Frazier OH; Glass DJ; Taegtmeyer H
J Mol Cell Cardiol; 2014 Jul; 72():168-76. PubMed ID: 24650875
[TBL] [Abstract][Full Text] [Related]
8. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
9. Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination.
Zhao D; Zhong G; Li J; Pan J; Zhao Y; Song H; Sun W; Jin X; Li Y; Du R; Nie J; Liu T; Zheng J; Jia Y; Liu Z; Liu W; Yuan X; Liu Z; Song J; Kan G; Li Y; Liu C; Gao X; Xing W; Chang YZ; Li Y; Ling S
Circulation; 2021 Aug; 144(9):694-711. PubMed ID: 34139860
[TBL] [Abstract][Full Text] [Related]
10. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.
Li HH; Kedar V; Zhang C; McDonough H; Arya R; Wang DZ; Patterson C
J Clin Invest; 2004 Oct; 114(8):1058-71. PubMed ID: 15489953
[TBL] [Abstract][Full Text] [Related]
11. AMP-activated protein kinase regulates E3 ligases in rodent heart.
Baskin KK; Taegtmeyer H
Circ Res; 2011 Oct; 109(10):1153-61. PubMed ID: 21921267
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
13. Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1-mediated gene expression in vivo.
Willis MS; Wadosky KM; Rodríguez JE; Schisler JC; Lockyer P; Hilliard EG; Glass DJ; Patterson C
Cell Biochem Funct; 2014 Jan; 32(1):39-50. PubMed ID: 23512667
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation.
Chen C; Shen L; Cao S; Li X; Xuan W; Zhang J; Huang X; Bin J; Xu D; Li G; Kitakaze M; Liao Y
PLoS One; 2014; 9(8):e104040. PubMed ID: 25089522
[TBL] [Abstract][Full Text] [Related]
15. Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling.
Wadosky KM; Rodríguez JE; Hite RL; Min JN; Walton BL; Willis MS
Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E723-39. PubMed ID: 24425758
[TBL] [Abstract][Full Text] [Related]
16. Cardiac muscle ring finger-1 increases susceptibility to heart failure in vivo.
Willis MS; Schisler JC; Li L; Rodríguez JE; Hilliard EG; Charles PC; Patterson C
Circ Res; 2009 Jul; 105(1):80-8. PubMed ID: 19498199
[TBL] [Abstract][Full Text] [Related]
17. Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB.
Usui S; Maejima Y; Pain J; Hong C; Cho J; Park JY; Zablocki D; Tian B; Glass DJ; Sadoshima J
Circ Res; 2011 Jul; 109(2):161-71. PubMed ID: 21617130
[TBL] [Abstract][Full Text] [Related]
18. TAK1 Regulates Myocardial Response to Pathological Stress via NFAT, NFκB, and Bnip3 Pathways.
Li L; Chen Y; Li J; Yin H; Guo X; Doan J; Molkentin JD; Liu Q
Sci Rep; 2015 Nov; 5():16626. PubMed ID: 26564789
[TBL] [Abstract][Full Text] [Related]
19. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
20. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
